Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cardiovasc Pathol. 2018 Mar 24;34:50–57. doi: 10.1016/j.carpath.2018.03.002

Table 3.

Mosaic protei006Es with known dysregulation in cardiac disease.

Protein/Gene Disease Expression Change Samples Evaluated Citation(s)
MYL4, ACTN2, ACTA1, RTN4, MYOM1, ODC1, PAM Dilated Cardiomyopathy 181 [20], [21], [22], [23], [24], [25]
MYL4, ACTN2, ACTA1, RTN4 Ischemic Cardiomyopathy 57 [20], [21], [25]
FHL2 Dilated Cardiomyopathy 73 [24]
FHL2 Ischemic Cardiomyopathy 73 [24]
MYL4 Congenital heart disease 27 [26]
MYL4, MYL6 End stage LV failure 8a [27]
PFKM Right heart failure 24b [28]

Samples are human unless otherwise denoted.

a

Dog samples;

b

Rat samples